Raj Chovatiya, MD, PhD

Case 3 Continued: How to Have Conversation About Risk of Biologics and Length of Therapy

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 3 Continued: Impressions

Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 3: 12-Year-Old-Female With Atopic Dermatitis

Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Addressing Injectable Medication in Children

Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Importance of Combination Therapy and Shared Decision Making

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Barriers to Treatment Adherence

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Impressions and Recommendations

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2: 7-Year-Old Female With Atopic Dermatitis

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1 Continued: Treatments Beyond Topical Agents and the Use of Dupixent

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1 Continued: Clinical Impressions

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1: 2-Year-Old Male With Atopic Dermatitis

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Unmet Needs in Managing Atopic Dermatitis

Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Key Takeaways for Atopic Dermatitis Management

Elizabeth A. Swanson, MD, and Raj. J. Chovatiya, MD, PhD, examine challenges in managing atopic dermatitis and explore the evolving treatment landscape.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Patient Advocacy for Atopic Dermatitis

Korey Capozza, MPH; Elizabeth A. Swanson, MD; and Taylor Capps share pearls for patients and their families managing atopic dermatitis.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Barriers to Access for Atopic Dermatitis Therapies

Korey Capozza, MPH, highlights the importance of patient advocacy in the atopic dermatitis journey.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Role of Disease-Modifying Therapies for Atopic Dermatitis Treatment

Raj J. Chovatiya, MD, PhD; Elizabeth A. Swanson, MD; Tina Capps; and Taylor Capps assess barriers in finding and obtaining atopic dermatitis treatments.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Pediatric Atopic Dermatitis: Considerations and Challenges With Oral Therapies

Elizabeth A. Swanson, MD, discusses the safety and efficacy of dupilumab in treating moderate to severe atopic dermatitis, and Taylor Capps shares her journey with dupilumab from insurance approvals through receiving treatment.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Challenges With Available Atopic Dermatitis Treatments for Pediatric Patients

Peter A. Lio, MD, describes the challenges pediatric patients face with oral therapies for atopic dermatitis, focusing on ease of administration and patient adherence.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Advice for Curating an Atopic Dermatitis Treatment Plan

Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, highlight challenges physicians face with the available atopic dermatitis treatments for pediatric patients.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Nonpharmacological Approaches to Treat Pediatric Atopic Dermatitis

Dr Peter A. Lio shares his advice for curating an atopic dermatitis treatment plan and explains the difference between rescue and maintenance treatments.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Defining Treatment Success in Patients With Atopic Dermatitis

Dr Brittany G. Craiglow provides an overview of her approach to use of nonpharmacological agents in the treatment of her pediatric patients with atopic dermatitis.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Pediatric Atopic Dermatitis Treatment Landscape

Raj Chovatiya, MD, PhD, and Brittany G. Craiglow, MD, share their opinions on how they assess and what they define as treatment success in their pediatric patients suffering from atopic dermatitis.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Role of Atopic Disease Burden Across Different Life Stages

Experts in dermatology review the treatment landscape for pediatric patients with atopic dermatitis.

Raj Chovatiya, MD, PhD;Brittany Craiglow, MD;Peter Lio, MD

Pharmacologic Treatment Options for Atopic Dermatitis

Dr Brittany G. Craiglow discusses the impact of disease burden on both the patient and their caregivers, with a focus on how this burden evolves as a patient ages.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Using Multidisciplinary Care to Optimize Atopic Dermatitis Treatment

Raj J. Chovatiya, MD, PhD, reviews goals of therapy for patients with atopic dermatitis and comments on the use of various topical therapies and systemic agents for disease management.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Patient Selection for Atopic Dermatitis Therapies

Korey Capozza, MPH, examines the role of multidisciplinary care for patients with atopic dermatitis, and Taylor Capps shares the impact of atopic dermatitis on mental health.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Approaching the Management of Atopic Dermatitis

Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

The Effect of Atopic Dermatitis on Pediatric and Adult Patients

Raj J. Chovatiya, MD, PhD, discusses the level of awareness of atopic dermatitis within the medical community and approaching the management of disease.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

Clinical Presentation of Atopic Dermatitis

Elizabeth A. Swanson, MD, describes the burden of atopic dermatitis on the pediatric and adult patient populations.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH